S$120.00 for 30 caps
Product of Singapore
Manufactured in Taiwan
Naturext™ Immune+ AC Essence is a cancer preventive health supplement made from powdered Antrodia Camphorate Mycelia, a rare fungus found naturally only in Taiwan.
The Chinese have used Antrodia Camphorate (AC) in traditional medicine as a cancer preventive health supplement in Taiwan for more than 50 years. Triterpenes - the most important bioactive ingredient found in AC - is a compound which exhibits anti-cancer, anti-virus, anti-oxidatnt, hepatoprotection and cholesterol inhibition properties.
Compared to the well known Ganoderma Lucidium (Lingzhi) where less than 50 types of Triterpenes are found, AC contains more than 200 types of Triterpenes. In addition, the concentration of Triterpenes found in AC is 10-15 times higher than Ganoderma Lucidium.
Recently, scientists discovered and patented new active anti-cancer compound Antroqinonol. Antroqinonol is a unique compound only found in AC. Various clinical tests using Antroqinonol proved it effective against cancerous cells.
Naturext™ Immune+ AC Essence also uses a patented solid state fermentation process to cultivate Antrodia Camphorata to ensure highest quality and consistency in its manufacturing process. In vitro experiments have shown that the cultivated Naturext™ Immune+ AC Essence with active anti cancer compound Antroquinonol (1.5% w/w) demonstrated superior anti cancer cell viability performance against wild Antrodia Camphorata.
Product Information:
Dehydrated, finely ground powder of Antrodia
Camphorata Mycelia which is cultivated with
patented solid state fermentation process.
Active Constituents:
• Triterpenes
• Antroquinonol (0.2% w/w)
Indication & Purported Uses:
• Treatment of alcohol induced hepatitis
• Anti-allergenic, strengthen immune function
• Anti-cancer, chemoprevention
• Anti-fatigue, anti-oxidation, anti-LDL cholesterol synthesis
• Anti-viral Hepatitis, Anti-hepatoxication, Hepatoprotection
• Treatment of Autoimmune diseases
Pharmacological Properties and Modes of Actions:
Antroquinonol™ could inhibit proliferation of liver, lung, breast & prostate cancer cells.o Antroquinonol induced S phase arrest of HepG2 cells when they are pretreated with synchronization.o After synchronized with Antroquinonol decrease all cell cycle regulatory protein & cell growth related protein (including cyclin A, cyclin D, cyclin E, cdk2, cdk4, Rb, p53, Akt and MAPK).o Antroquinonol inhibit protein synthesis through translation related protein 4E-BP1 and elF4E
Antroquinonol™ for the treatment of multiple forms of cancer has been proven in vivo. The compound has passed in-vivo efficacy, ADME/toxicology for at least three kinds of cancer (NSCLC, liver and breast cancer) compared with the chemotherapy drugs Mitomycin and Taxol as positive control. No drug resistance was observed during in vivo studies. This indicates that the drug can be considered a long-term orally-administered cancer therapy.
1. Planta Med. 2007 Oct;73(13):1412-5. Epub 2007 Oct 11. “A new cytotoxic agent from solid-state fermented mycelium of Antrodia camphorata.
Application:
Safety:
No known contraindication
• In vitro cytotoxity (5000 mg/ml),
• Genocytotoxicity (5000 mg/ml),
• Acute toxicity (2000 mg/kg)
US FDA Patent Information:
* Antroquinonol_Patent_US7342137.pdf (Cytotoxic Compound)
* Antroquinonol_Patent_US7385088.pdf (Anti Cancer application)
* Antroquinonol_Patent_US7411003.pdf (Inhibition of Hepatitis B)
* Antroquinonol_Patent_US7456225.pdf (Liver Protection)
* Antroquinonol_Patent_US7501454.pdf (Treatment of Autoimmune Diseases)
* Antroquinonol_Patent_US7468392.pdf (Anti Fatique)
* Antroquinonol_Patent_US20080119565.pdf (Treatment of Cancers)